Labcorp Holdings Inc.
LH- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0000920148
In the last 90 days, Labcorp Holdings Inc. insiders filed 0 open-market purchases and 4 sales; 1,064 institutions reported holding it in 13F filings for Q2 2026, worth $22.2B in total; Weitz Investment Management is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 31, 2026, 1:11 AM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 17, 2026 | Feb 6, 2025 | Feb 15, 2024 | Feb 16, 2023 | Feb 10, 2022 |
| Revenue | $14.0B | $13.0B | $12.2B | $14.9B | $16.1B |
| Cost of revenue | $9.94B | $9.38B | $8.80B | $10.5B | $10.5B |
| Gross profit | $4.01B | $3.62B | $3.36B | $4.39B | $5.62B |
| Selling, general and administrative | $2.22B | $2.23B | $2.02B | $2.00B | $1.95B |
| Operating income | $1.38B | $1.09B | $725.6M | $1.77B | $3.26B |
| Interest expense | $224.1M | $208.3M | $199.6M | $180.3M | $212.1M |
| Income tax | $229.8M | $212.4M | $188.5M | $302.0M | $747.1M |
| Net income | $876.5M | $746.0M | $418.0M | $1.28B | $2.38B |
| EPS, basic | $10.54 | $8.89 | $4.80 | $14.05 | $24.60 |
| EPS, diluted | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 |
| Weighted shares, basic | 83.2M | 83.9M | 87.1M | 91.1M | 96.7M |
| Weighted shares, diluted | 83.8M | 84.4M | 87.6M | 91.6M | 97.5M |
| Margins and growth | |||||
| Gross margin | 28.8% | 27.9% | 27.7% | 29.5% | 34.9% |
| Operating margin | 9.9% | 8.4% | 6.0% | 11.9% | 20.2% |
| Net margin | 6.3% | 5.7% | 3.4% | 8.6% | 14.7% |
| Revenue growth, year over year | +7.2% | +7.0% | −18.3% | −7.7% | +15.3% |
| Net income growth, year over year | +17.5% | +78.5% | −67.3% | −46.2% | +52.8% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 17, 2026 | Feb 6, 2025 | Feb 15, 2024 | Feb 16, 2023 | Feb 10, 2022 |
| Cash and equivalents | $532.3M | $1.52B | $536.8M | $430.0M | $1.47B |
| Accounts receivable | $2.10B | $1.94B | $1.91B | $2.22B | $2.26B |
| Inventory | $534.7M | $493.2M | $474.6M | $470.6M | $401.4M |
| Total current assets | $4.02B | $4.81B | $3.77B | $4.63B | $5.33B |
| Property, plant and equipment | $3.08B | $3.05B | $2.91B | $2.96B | $2.82B |
| Goodwill | $6.79B | $6.37B | $6.14B | $8.12B | $7.96B |
| Intangible assets | $3.60B | $3.49B | $3.34B | $3.95B | $3.74B |
| Total assets | $18.4B | $18.4B | $16.7B | $20.2B | $20.4B |
| Accounts payable | $840.8M | $875.8M | $827.5M | $934.8M | $621.3M |
| Short-term debt | $500.1M | $1.00B | $999.8M | $301.3M | $1.50M |
| Total current liabilities | $2.82B | $3.33B | $3.23B | $3.08B | $2.78B |
| Long-term debt | $5.08B | $5.33B | $4.05B | $5.04B | $5.42B |
| Total liabilities | $9.76B | $10.3B | $8.83B | $10.0B | $10.1B |
| Shareholders' equity | $8.62B | $8.05B | $7.88B | $10.1B | $10.3B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 17, 2026 | Feb 6, 2025 | Feb 15, 2024 | Feb 16, 2023 | Feb 10, 2022 |
| Operating cash flow | $1.64B | $1.59B | $1.33B | $1.96B | $3.11B |
| Capital expenditures | $434.5M | $489.9M | $453.6M | $481.9M | $460.4M |
| Free cash flow | $1.21B | $1.10B | $874.1M | $1.47B | $2.65B |
| Depreciation and amortization | $681.1M | $643.5M | $577.3M | $633.9M | $745.1M |
| Stock-based compensation | $125.8M | $116.7M | $128.7M | $144.1M | $153.7M |
| Dividends paid | $240.7M | $243.1M | – | – | – |
| Share buybacks | $450.0M | $250.1M | $1.00B | $1.10B | $1.67B |
| Investing cash flow | -$1.19B | -$1.37B | -$1.17B | -$1.65B | -$884.6M |
| Financing cash flow | -$1.46B | $779.9M | -$59.3M | -$1.32B | -$2.07B |
| Net change in cash | -$986.4M | $981.9M | $106.8M | -$1.04B | $151.9M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.9% | 0.9% | 1.1% | 1.0% | 1.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 29, 2026 | 81.2M | −2.1% | SEC |
| Aug 4, 2026 | 81.1M | −2.4% | SEC |
| May 1, 2026 | 82.0M | −2.0% | SEC |
| Feb 23, 2026 | 82.4M | −1.6% | SEC |
| Oct 30, 2025 | 82.9M | −0.9% | SEC |
| Jul 31, 2025 | 83.1M | −1.0% | SEC |
| Apr 28, 2025 | 83.7M | −0.7% | SEC |
| Feb 24, 2025 | 83.7M | −0.5% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.